Juncture Wealth Strategies, LLC Eton Pharmaceuticals, Inc. Transaction History
Juncture Wealth Strategies, LLC
- $298 Million
- Q3 2025
A detailed history of Juncture Wealth Strategies, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Juncture Wealth Strategies, LLC holds 16,968 shares of ETON stock, worth $323,240. This represents 0.12% of its overall portfolio holdings.
Number of Shares
16,968Holding current value
$323,240% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
88Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$54.5 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$38.7 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$25 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$22.4 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$11.3 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $482M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...